[1]
Leemol, V. et al. 2026. Navigating South Korea’s MFDS Regulatory Requirements for Indian API Manufacturers despite holding USFDA approval. Journal of Comprehensive Pharmaceutical Sciences . 1, 2 (Nov. 2026), 40–45.